Intelligent Asthma Monitoring Devices Market Report 2024

The intelligent asthma monitoring devices market size has grown strongly in recent years. It will grow from $0.93 billion in 2023 to $1.0 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historical period can be attributed to several factors, including advancements in guidelines for asthma diagnosis, a supportive regulatory environment, rising approvals for asthma monitoring devices, a growing emphasis on preventive healthcare practices, and increased adoption of smart inhalers to enhance treatment adherence.

The intelligent asthma monitoring devices market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to several factors, including the rising incidence of respiratory diseases, the expanding geriatric population, urbanization and environmental pollution, increasing cases of asthma, and overall population growth worldwide. Major trends anticipated during this period include partnerships between pharmaceutical firms and smart inhaler manufacturers, the development of smartphone apps and mobile health solutions for asthma management, the application of AI-powered algorithms and machine learning for early prediction of asthma attacks, and the integration of smart inhalers with digital health platforms.

The intelligent asthma monitoring device market is set to grow due to an increase in respiratory diseases. Respiratory diseases encompass a wide range of medical conditions affecting breathing organs and tissues, exacerbated by factors such as rising air pollution, smoking rates, urbanization, and an aging population. Intelligent asthma monitoring devices play a crucial role by providing real-time data on lung function and environmental triggers. This capability enables early symptom detection and personalized treatment adjustments, significantly enhancing management and quality of life for patients with respiratory diseases. For example, in 2022, the American Lung Association reported a rise in chronic obstructive pulmonary disease (COPD) cases among males, highlighting the market's growth driven by increased respiratory disease occurrences.

Leading companies in the intelligent asthma monitoring devices market are focusing on technological advancements to improve patient monitoring and treatment outcomes. One such innovation includes AI-powered wearable lung monitors, which integrate artificial intelligence with wearable sensors. These devices monitor and analyze lung function and respiratory health in real time. For instance, Respira Labs launched Sylvee in December 2021, an AI-powered wearable lung monitor designed to assess lung function in conditions such as COPD, COVID-19, and asthma. Sylvee utilizes embedded speakers and microphones placed on the rib cage to measure changes in acoustic resonance, reflecting lung air volume changes. The device aims for high accuracy in measuring lung capacity and air trapping through extensive patient trials.

In February 2024, Aevice Health partnered with Jiva.ai to develop an AI-driven platform for predicting asthma exacerbations. This collaboration combines Aevice Health's smart stethoscope technology with Jiva.ai's AI platform, enabling remote monitoring and biomarker tracking to predict and manage asthma exacerbations effectively. Jiva.ai, based in the UK, specializes in no-code AI technology for healthcare applications, enhancing respiratory health management through predictive analytics and remote monitoring solutions.

Major companies operating in the intelligent asthma monitoring devices market are AstraZeneca plc, 3M Company, Boehringer Ingelheim International GmbH, Teva Pharmaceuticals Industries Ltd., ResMed Inc, Aptar Pharma Inc, OPKO Health Ltd, Sensirion AG, Vectura Group plc, Circassia Pharmaceuticals, Propeller Health, Vitalograph Ltd, Volansys Technologies Pvt Ltd, Amiko Digital Health Inc, Pneuma Respiratory Inc, Quvium, FindAir Sp. z o., Monitored Therapeutics Inc, Respiri Ltd, NuvoAir AB, Health Care Originals Inc, AEvice Health.

North America was the largest region in the intelligent asthma monitoring devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intelligent asthma monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intelligent asthma monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intelligent asthma monitoring devices are advanced technological tools that integrate sensors, connectivity features, and data analytics capabilities. These devices offer real-time monitoring, personalized insights, and timely alerts related to asthma symptoms and environmental triggers, aiming to assist both asthma patients and healthcare providers in managing the condition effectively.

The main types of products in intelligent asthma monitoring devices include wearable asthma monitoring devices, smart inhalers, dry powdered inhalers, and nebulizers. Wearable asthma monitoring devices are compact electronic devices worn to track and monitor asthma symptoms such as breathing rate and cough frequency, providing continuous real-time data for improved management. These devices utilize various technologies, including manually operated inhalers and digitally operated inhalers. They are utilized across various healthcare settings such as hospitals, clinics, retail pharmacies, online pharmacies, and others.

The intelligent asthma monitoring devices market research report is one of a series of new reports that provides intelligent asthma monitoring devices market statistics, including intelligent asthma monitoring devices industry global market size, regional shares, competitors with an intelligent asthma monitoring devices market share, detailed intelligent asthma monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the intelligent asthma monitoring devices industry. This intelligent asthma monitoring device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intelligent asthma monitoring devices market consists of sales of smartwatches, fitness trackers, spirometers, and peak flow meters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.